Skip to main content

Hydrocortisone

NDC 45802-014 · Padagis Israel Pharmaceuticals Ltd

Generic nameHydrocortisone

Dosage formOINTMENT

RouteTOPICAL

Active ingredient(s)HYDROCORTISONE

Strength25 mg/g

Pharmacologic classCorticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]

Marketing categoryANDA

Packages

45802-014-02 — 1 TUBE in 1 CARTON (45802-014-02) / 20 g in 1 TUBE

45802-014-05 — 454 g in 1 JAR (45802-014-05)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

43473-054 — HYDROCORTISONE, 43473-092 — HYDROCORTISONE, 43473-116 — HYDROCORTISONE, 43473-311 — Hydrocortisone, 43473-313 — Hydrocortisone, 43742-1275 — Hydrocortisone, 43749-620 — Hydrocortisone, 44577-623 — HYDROCORTISONE, 44911-0275 — Hydrocortisone, 45802-004 — Hydrocortisone, 45802-276 — hydrocortisone, 45802-438 — Hydrocortisone, 45802-937 — hydrocortisone, 46122-822 — Hydrocortisone Cream 1%, 47682-211 — Hydrocortisone, 47682-397 — Hydrocortisone, 47682-933 — Hydrocortisone, 49035-707 — Hydrocortisone, 49035-732 — Hydrocortisone, 49035-973 — Hydrocortisone, +498 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels